Pulmonary Drug Delivery Systems Market Research Report 2018- 2025, Now Available At MRC
This report studies the
global Pulmonary Drug Delivery Systems market status and forecast, categorizes
the global Pulmonary Drug Delivery Systems market size (value & volume) by
key players, type, application, and region. This report focuses on the top
players in North America, Europe, China, Japan, Southeast Asia India and Other
regions (Middle East & Africa, Central & South America).
Pulmonary drug delivery
systems are used to the treatment of various respiratory diseases like asthma
and chronic obstructive pulmonary disease (COPD), delivering locally acting
drugs directly to their site of action. Advantages of pulmonary drug delivery
systems over oral drugs is the excellent capability of absorbing
pharmaceuticals, due to the large absorptive surface area of lungs
(approximately 70-140 m2 in adult humans having extremely thin absorptive
mucosal membrane) and good blood supply.
With better performance, the development of DPIs is faster than the MDIs. In the future, DPIs will occupy larger market share and replace the MDIs gradually. In addition, the market share of nebulizers will be smaller.
As WHO said, the COPD will become the world's third-leading cause of death by 2030. With the air pollution more and more serious, patients with respiratory diseases will be more and more, which means larger and larger demand for pulmonary drug delivery systems.
The global Pulmonary Drug Delivery Systems market is valued at 2560 million US$ in 2017 and will reach 3570 million US$ by the end of 2025, growing at a CAGR of 4.2% during 2018-2025.
The major players covered in this report
3M
GSK
AstraZeneca
Cipla
Chiesi
Boehringer Ingelheim
Aptar
Novartis
Philips Respironics
Omron Healthcare
PARI
Skyepharma
CareFusion
Shanghai Huarui
Taian Character
Chia Tai Tianqing
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India
With better performance, the development of DPIs is faster than the MDIs. In the future, DPIs will occupy larger market share and replace the MDIs gradually. In addition, the market share of nebulizers will be smaller.
As WHO said, the COPD will become the world's third-leading cause of death by 2030. With the air pollution more and more serious, patients with respiratory diseases will be more and more, which means larger and larger demand for pulmonary drug delivery systems.
The global Pulmonary Drug Delivery Systems market is valued at 2560 million US$ in 2017 and will reach 3570 million US$ by the end of 2025, growing at a CAGR of 4.2% during 2018-2025.
The major players covered in this report
3M
GSK
AstraZeneca
Cipla
Chiesi
Boehringer Ingelheim
Aptar
Novartis
Philips Respironics
Omron Healthcare
PARI
Skyepharma
CareFusion
Shanghai Huarui
Taian Character
Chia Tai Tianqing
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India
Full report with Table of Content:
https://marketreportscenter.com/reports/577959/global-pulmonary-drug-delivery-systems-sales-market-report-2018
We can also provide the
customized separate regional or country-level reports, for the following
regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Nebulizers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
COPD
Asthma
Others
The study objectives of this report are:
To analyze and study the global Pulmonary Drug Delivery Systems sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Pulmonary Drug Delivery Systems players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Nebulizers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
COPD
Asthma
Others
The study objectives of this report are:
To analyze and study the global Pulmonary Drug Delivery Systems sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Pulmonary Drug Delivery Systems players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
…
About
Market Reports Center;
Market Reports Center is an e-commerce platform
obliging the needs of knowledge workers, experts, professionals who are subject
to market research information for their work, or to make strategic business
decisions. We are dedicated to create a comprehensive offering of market
research which is accurate, credible and affordable.
Connect
for more details:
Sam
Collins
Market
Reports Center
1-646-883-3044
(US)
Comments
Post a Comment